Back to
CAPTRUST FINANCIAL ADVISORS
CBAY12 quarters
Position history for
CAPTRUST FINANCIAL ADVISORS's holdings in CYMABAY THERAPEUTICS INC
As of its Q4 2023 13F, Captrust held 30,973 shares of CBAY (Cymabay Therapeutics), worth $731,582. Captrust's 13F filings listed CBAY from Q3 2023 to Q4 2023, 2 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$25,000
Total Shares Change
-3,500
Quarter-by-Quarter History
Other major holders of CBAY: Avoro Capital Advisors LLC, BlackRock Finance, Inc., RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.